26th Annual Scientific Assembly

Medication Assisted Treatment (MAT) Waiver Training

Produced by EM Docs for EM Docs

Jointly provided by the American Academy of Addiction Psychiatry, a DATA 2000 sponsoring organization and Providers Clinical Support System

Sunday, April 19 
8:00am-5:00pm

 

Course Description

Emergency physicians are uniquely positioned to impact the opioid epidemic because the emergency department is where these patients come for care. This course will provide the tools to turn lives around with best practice addiction treatments and satisfies eight hours of training required by federal law to prescribe buprenorphine, the most effective treatment for opioid use disorder.

← Back to all pre-conference courses

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Emergency Medicine (AAEM) and the American Academy of Addiction Psychiatry (AAAP). The American Academy of Emergency Medicine (AAEM) is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation Statement

The American Academy of Emergency Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a maximum of 8.25 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those completing the course will be able to complete the waiver application online.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

 

Educational Objectives:

This course will provide the participant (with a focus on emergency providers) with a knowledge of:

  1. Opioid Use Disorder as a medical illness: dependence vs. addiction.
  2. Overview and efficacy of MAT vs. non-agonist treatment.
  3. Fundamentals of methadone and naltrexone treatment.
  4. Pharmacology of buprenorphine.
  5. Indications for and dosing algorithms and potential complications of, buprenorphine administration in the ED.
  6. Management of buprenorphine precipitated withdrawal.
  7. Successful ED buprenorphine program development, and referral system.
  8. Co-occurring psychiatric disorders and SUD disorders, with relationship to treatment of OUD.
  9. Harm reduction strategies, including rationale and evidence for community naloxone distribution, including a discussion of common misconceptions about this medication
  10. Legal & regulatory considerations, including buprenorphine prescribing rules, the “72 hour rule”, DEA license "X-waiver" patient number limits and “42 CFR Part 2.”

 

Course Eligibility

Please confirm your eligibility prior to registering: To apply for a waiver you must have a valid medical license and an active DEA number. Residents may take the course and apply for their waiver when they receive their DEA license. Medical students are also welcome to take the course.

 

Course Fee

  • AAEM Member: Early Bird $150 | Late (after March 20) $250      
  • Non-AAEM Member: Early Bird $300 | Late (after March 20): $400
  • AAEM/RSA Resident Member: Early Bird $100 | Late (after March 20) $200
  • Resident Non-Member: Early Bird $200 | Late (after March 20): $300
  • Medical Student-Member: Early Bird $100 | Late (after March 20) $200
  • Medical Student-Non-Member: Early Bird $200 | Late (after March 20) $300

Registration opens Fall 2019

 

Tentative Course Schedule

Sunday, April 19, 2020       

8:00am-9:00am                       

Welcome, Introductions, Plan for the Day
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

Module 1: Course Overview
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

Module 2: Neurobiology, OUD as a Medical Disease
Reuben Strayer, MD FRCP FAAEM

9:00am-9:30am 

Case #1: Addicted School Teacher (Clinic Case)
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

Case #2: A Sick Elderly Patient (ED Case)
Reuben Strayer, MD FRCP FAAEM

9:30am-9:55am 

Module 3: Pharmacology of Methadone and Naltrexone
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

9:55am-10:10am 

Break

10:10am-10:35am 

Module 4: Pharmacology of Buprenorphine
Reuben Strayer, MD FRCP FAAEM

10:35am-10:50am

Case #3:  Treatment Goals (Clinic Case)
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

10:50am-11:40am

Module 5: Opioid Withdrawal Management
Reuben Strayer, MD FRCP FAAEM

Module 6: Initiation of MAT with Buprenorphine in the ED
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

11:40am-12:00pm

Case #4: Methadone and Withdrawal (ED Case)
Reuben Strayer, MD FRCP FAAEM

12:00pm-12:30pm

Lunch Break (Box lunch included)

12:30pm-12:50pm

Case #5: Precipitated Withdrawal Management (ED Case)
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

12:50pm-1:40pm

Module 7: Urine Drug Testing (UDS) and Other Laboratory Tests
Reuben Strayer, MD FRCP FAAEM

Module 8: Successful Systems Building: Bridging Patients from the ED
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

1:40pm-2:10pm

Case #6: Overdose Case (ED Case)
Reuben Strayer, MD FRCP FAAEM

Case #7: Opioid Withdrawal & Pain Management (ED Case)
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

2:10pm-2:40pm

Module 9: Special Populations
Reuben Strayer, MD FRCP FAAEM

2:40pm-2:55pm 

Break

2:55pm-3:20pm

Module 10: Pain Management for Patients with OUD
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

3:20pm-3:50pm

Case #8: Pain Management (ED Case)
Reuben Strayer, MD FRCP FAAEM

Case #9: Addiction and Depression (Clinic Case)
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

3:50pm-4:40pm

Module 11: Counseling, Motivational Interviewing
Reuben Strayer, MD FRCP FAAEM

Module 12: Legal & Regulatory Considerations
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

4:40pm-5:00pm 

Completion of DEA Waiver; Course Evaluations
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE

*Schedule subject to change.

 

Course Director

Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE 
Department of Emergency Medicine & Department of Behavioral Health (Addiction Medicine Consult Service), Presbyterian Health System, Santa Fe & Espanola, NM; Medical Director, New Mexico Treatment Services (Opioid Addiction Treatment Program), Farmington, NM

 

Faculty

Reuben Strayer, MD FRCP FAAEM
Associate Medical Director, Department of Emergency Medicine, Maimonides Medical Center, Brooklyn, NY

 

Sponsoring Groups

  • American Academy of Addiction Psychiatry (AAAP)
  • Providers Clinical Support System (PCSS)